Polarized Tissue-Derived Macrophages Display Enhanced M2d Phenotype after Prolonged Stimulation with Adenosine A2A Receptor Agonist in the Presence of LPS
Julia Barilo , Mariane Ratsimor , Agnes Chan , Hannah Hembruff , Sam Basta
Frontiers in Bioscience-Landmark ›› 2025, Vol. 30 ›› Issue (2) : 27638
Macrophages (Mφ) are innate immune cells known for their different activation phenotypes, classically described as falling within two broad categories, M1 and M2. The latter were originally described as alternatively activated M2 cells to differentiate them from classically activated M1 cells. M2 cells were later classified into M2a (interleukin (IL)-4), M2b (immune complex), M2c (IL-10) and M2d (5-(N-ethylcarboxamido) adenosine (NECA) + lipopolysaccharide (LPS)) based on their inducing stimuli. Considering the established role of M2d/tumour-associated macrophage (TAM) cells within cancer initiation and proliferation, expanding on the knowledge of M2d characteristics can provide fundamental information for Mφ targeted immunotherapy. The precise characterization of M2d cells derived from tissues has not been described in detail.
Our study focused on spleen-derived macrophages (SpM), which were also compared to bone marrow-derived macrophages (BMDMs).
By investigating different conditions for M2d-specific stimulation and employing various assays including functional tests, we show how Mφ M2d (NECA + LPS) polarization can be affected by prolonged culture conditions to induce a phenotype that was clearly different from M2a cells.
This work offers new insights into the properties of primary M2d Mφ following extended stimulation with LPS and NECA.
5-(N-ethylcarboxamido) adenosine (NECA) / cytokines / polarization / LPS
| [1] |
Banete A, Barilo J, Whittaker R, Basta S. The Activated Macrophage - A Tough Fortress for Virus Invasion: How Viruses Strike Back. Frontiers in Microbiology. 2022; 12: 803427. https://doi.org/10.3389/fmicb.2021.803427. |
| [2] |
Murray PJ, Wynn TA. Protective and pathogenic functions of macrophage subsets. Nature Reviews. Immunology. 2011; 11: 723–737. https://doi.org/10.1038/nri3073. |
| [3] |
Kim J, Gambhir V, Alatery A, Basta S. Delivery of Exogenous Antigens to Induce Cytotoxic CD8+ T Lymphocyte Responses. Journal of Biomedicine & Biotechnology. 2010; 2010: 218752. https://doi.org/10.1155/2010/218752. |
| [4] |
Alatery A, Siddiqui S, Chan M, Kus A, Petrof EO, Basta S. Cross, but not direct, presentation of cell-associated virus antigens by spleen macrophages is influenced by their differentiation state. Immunology and Cell Biology. 2010; 88: 3–12. https://doi.org/10.1038/icb.2009.90. |
| [5] |
Pozzi LAM, Maciaszek JW, Rock KL. Both dendritic cells and macrophages can stimulate naive CD8 T cells in vivo to proliferate, develop effector function, and differentiate into memory cells. Journal of Immunology (Baltimore, Md.: 1950). 2005; 175: 2071–2081. https://doi.org/10.4049/jimmunol.175.4.2071. |
| [6] |
Bernhard CA, Ried C, Kochanek S, Brocker T. CD169+ macrophages are sufficient for priming of CTLs with specificities left out by cross-priming dendritic cells. Proceedings of the National Academy of Sciences of the United States of America. 2015; 112: 5461–5466. https://doi.org/10.1073/pnas.1423356112. |
| [7] |
Gordon S, Taylor PR. Monocyte and macrophage heterogeneity. Nature Reviews. Immunology. 2005; 5: 953–964. https://doi.org/10.1038/nri1733. |
| [8] |
Varin A, Gordon S. Alternative activation of macrophages: immune function and cellular biology. Immunobiology. 2009; 214: 630–641. https://doi.org/10.1016/j.imbio.2008.11.009. |
| [9] |
Martinez FO, Gordon S. The M1 and M2 paradigm of macrophage activation: time for reassessment. F1000prime Reports. 2014; 6: 13. https://doi.org/10.12703/P6-13. |
| [10] |
Stein M, Keshav S, Harris N, Gordon S. Interleukin 4 potently enhances murine macrophage mannose receptor activity: a marker of alternative immunologic macrophage activation. The Journal of Experimental Medicine. 1992; 176: 287–292. https://doi.org/10.1084/jem.176.1.287. |
| [11] |
Pinhal-Enfield G, Ramanathan M, Hasko G, Vogel SN, Salzman AL, Boons GJ, et al. An angiogenic switch in macrophages involving synergy between Toll-like receptors 2, 4, 7, and 9 and adenosine A(2A) receptors. The American Journal of Pathology. 2003; 163: 711–721. https://doi.org/10.1016/S0002-9440(10)63698-X. |
| [12] |
Ferrante CJ, Pinhal-Enfield G, Elson G, Cronstein BN, Hasko G, Outram S, et al. The adenosine-dependent angiogenic switch of macrophages to an M2-like phenotype is independent of interleukin-4 receptor alpha (IL-4Rα) signaling. Inflammation. 2013; 36: 921–931. https://doi.org/10.1007/s10753-013-9621-3. |
| [13] |
Li P, Ma C, Li J, You S, Dang L, Wu J, et al. Proteomic characterization of four subtypes of M2 macrophages derived from human THP-1 cells. Journal of Zhejiang University. Science. B. 2022; 23: 407–422. https://doi.org/10.1631/jzus.B2100930. |
| [14] |
Zhang Q, Sioud M. Tumor-Associated Macrophage Subsets: Shaping Polarization and Targeting. International Journal of Molecular Sciences. 2023; 24: 7493. https://doi.org/10.3390/ijms24087493. |
| [15] |
Mulder R, Banete A, Seaver K, Basta S. M(IL-4) Tissue Macrophages Support Efficient Interferon-Gamma Production in Antigen-Specific CD8+ T Cells with Reduced Proliferative Capacity. Frontiers in Immunology. 2017; 8: 1629. https://doi.org/10.3389/fimmu.2017.01629. |
| [16] |
Mulder R, Banete A, Basta S. Spleen-derived macrophages are readily polarized into classically activated (M1) or alternatively activated (M2) states. Immunobiology. 2014; 219: 737–745. https://doi.org/10.1016/j.imbio.2014.05.005. |
| [17] |
Chen Y, Song Y, Du W, Gong L, Chang H, Zou Z. Tumor-associated macrophages: an accomplice in solid tumor progression. Journal of Biomedical Science. 2019; 26: 78. https://doi.org/10.1186/s12929-019-0568-z. |
| [18] |
Alatery A, Basta S. An efficient culture method for generating large quantities of mature mouse splenic macrophages. Journal of Immunological Methods. 2008; 338: 47–57. https://doi.org/10.1016/j.jim.2008.07.009. |
| [19] |
Baxter EW, Graham AE, Re NA, Carr IM, Robinson JI, Mackie SL, et al. Standardized protocols for differentiation of THP-1 cells to macrophages with distinct M(IFNγ+LPS), M(IL-4) and M(IL-10) phenotypes. Journal of Immunological Methods. 2020; 478: 112721. https://doi.org/10.1016/j.jim.2019.112721. |
| [20] |
Banete A, Gee K, Basta S. Sustained IL-4 priming of macrophages enhances the inflammatory response to TLR7/8 ligand R848. Journal of Leukocyte Biology. 2022; 111: 401–413. https://doi.org/10.1002/JLB.3A0520-293RR. |
| [21] |
Ho VWH, Sly LM. Derivation and characterization of murine alternatively activated (M2) macrophages. Methods in Molecular Biology (Clifton, N.J.). 2009; 531: 173–185. https://doi.org/10.1007/978-1-59745-396-7_12. |
| [22] |
Siddiqui S, Alatery A, Kus A, Basta S. TLR engagement prior to virus infection influences MHC-I antigen presentation in an epitope-dependent manner as a result of nitric oxide release. Journal of Leukocyte Biology. 2011; 89: 457–468. https://doi.org/10.1189/jlb.0610357. |
| [23] |
Alothaimeen T, Seaver K, Mulder R, Gee K, Basta S. Granulocyte/Macrophage Colony-Stimulating Factor-Derived Macrophages Exhibit Distinctive Early Immune Response to Lymphocytic Choriomeningitis Virus Infection. Viral Immunology. 2020; 33: 477–488. https://doi.org/10.1089/vim.2019.0178. |
| [24] |
Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods (San Diego, Calif.). 2001; 25: 402–408. https://doi.org/10.1006/meth.2001.1262. |
| [25] |
Barilo J, Bouzeineddine NZ, Philippi A, Basta S. Polarized macrophage functions are affected differentially after CSF-1R inhibition with PLX5622. European Journal of Pharmacology. 2024; 984: 177059. https://doi.org/10.1016/j.ejphar.2024.177059. |
| [26] |
Hourani T, Perez-Gonzalez A, Khoshmanesh K, Luwor R, Achuthan AA, Baratchi S, et al. Label-free macrophage phenotype classification using machine learning methods. Scientific Reports. 2023; 13: 5202. https://doi.org/10.1038/s41598-023-32158-7. |
| [27] |
Xia T, Fu S, Yang R, Yang K, Lei W, Yang Y, et al. Advances in the study of macrophage polarization in inflammatory immune skin diseases. Journal of Inflammation (London, England). 2023; 20: 33. https://doi.org/10.1186/s12950-023-00360-z. |
| [28] |
Strizova Z, Benesova I, Bartolini R, Novysedlak R, Cecrdlova E, Foley LK, et al. M1/M2 macrophages and their overlaps - myth or reality? Clinical Science (London, England: 1979). 2023; 137: 1067–1093. https://doi.org/10.1042/CS20220531. |
| [29] |
Viola A, Munari F, Sánchez-Rodríguez R, Scolaro T, Castegna A. The Metabolic Signature of Macrophage Responses. Frontiers in Immunology. 2019; 10: 1462. https://doi.org/10.3389/fimmu.2019.01462. |
| [30] |
Petrina M, Martin J, Basta S. Granulocyte macrophage colony-stimulating factor has come of age: From a vaccine adjuvant to antiviral immunotherapy. Cytokine & Growth Factor Reviews. 2021; 59: 101–110. https://doi.org/10.1016/j.cytogfr.2021.01.001. |
| [31] |
Trus E, Basta S, Gee K. Who’s in charge here? Macrophage colony stimulating factor and granulocyte macrophage colony stimulating factor: Competing factors in macrophage polarization. Cytokine. 2020; 127: 154939. https://doi.org/10.1016/j.cyto.2019.154939. |
| [32] |
Bours MJL, Swennen ELR, Di Virgilio F, Cronstein BN, Dagnelie PC. Adenosine 5’-triphosphate and adenosine as endogenous signaling molecules in immunity and inflammation. Pharmacology & Therapeutics. 2006; 112: 358–404. https://doi.org/10.1016/j.pharmthera.2005.04.013. |
| [33] |
Köröskényi K, Kiss B, Szondy Z. Adenosine A2A receptor signaling attenuates LPS-induced pro-inflammatory cytokine formation of mouse macrophages by inducing the expression of DUSP1. Biochimica et Biophysica Acta. 2016; 1863: 1461–1471. https://doi.org/10.1016/j.bbamcr.2016.04.003. |
| [34] |
Antonioli L, Pacher P, Vizi ES, Haskó G. CD39 and CD73 in immunity and inflammation. Trends in Molecular Medicine. 2013; 19: 355–367. https://doi.org/10.1016/j.molmed.2013.03.005. |
| [35] |
Antonioli L, Fornai M, Blandizzi C, Pacher P, Haskó G. Adenosine signaling and the immune system: When a lot could be too much. Immunology Letters. 2019; 205: 9–15. https://doi.org/10.1016/j.imlet.2018.04.006. |
| [36] |
Haskó G, Kuhel DG, Chen JF, Schwarzschild MA, Deitch EA, Mabley JG, et al. Adenosine inhibits IL-12 and TNF-[alpha] production via adenosine A2a receptor-dependent and independent mechanisms. FASEB Journal: Official Publication of the Federation of American Societies for Experimental Biology. 2000; 14: 2065–2074. https://doi.org/10.1096/fj.99-0508com. |
| [37] |
Ramanathan M, Pinhal-Enfield G, Hao I, Leibovich SJ. Synergistic up-regulation of vascular endothelial growth factor (VEGF) expression in macrophages by adenosine A2A receptor agonists and endotoxin involves transcriptional regulation via the hypoxia response element in the VEGF promoter. Molecular Biology of the Cell. 2007; 18: 14–23. https://doi.org/10.1091/mbc.e06-07-0596. |
| [38] |
De Ponti C, Carini R, Alchera E, Nitti MP, Locati M, Albano E, et al. Adenosine A2a receptor-mediated, normoxic induction of HIF-1 through PKC and PI-3K-dependent pathways in macrophages. Journal of Leukocyte Biology. 2007; 82: 392–402. https://doi.org/10.1189/jlb.0107060. |
| [39] |
Khosrowpour Z, Soudi S, Hashemi SM. Number 1 Comparision of the Effects of Leishmania Soluble Antigen (LSA) and Lipopolysaccharide (LPS) on C57BL/6 Mice Macrophage Function. Immunoregulation. 2018; 1: 39–44. https://doi.org/10.32598/Immunoregulation.1.1.39. |
| [40] |
Kawakami T, Kawamura K, Fujimori K, Koike A, Amano F. Influence of the culture medium on the production of nitric oxide and expression of inducible nitric oxide synthase by activated macrophages in vitro. Biochemistry and Biophysics Reports. 2016; 5: 328–334. https://doi.org/10.1016/j.bbrep.2016.01.006. |
| [41] |
Banete A, Achita P, Harding K, Mulder R, Basta S. Immortalized murine macrophage cell line as a model for macrophage polarization into classically activated M (IFNgamma+ LPS) or alternatively activated M (IL-4) macrophages. Journal of Clinical & Cellular Immunology. 2015; 6: 4172. https://doi.org/10.4172/2155-9899.1000318. |
| [42] |
Rath M, Müller I, Kropf P, Closs EI, Munder M. Metabolism via Arginase or Nitric Oxide Synthase: Two Competing Arginine Pathways in Macrophages. Frontiers in Immunology. 2014; 5: 532. https://doi.org/10.3389/fimmu.2014.00532. |
| [43] |
Sonoki T, Nagasaki A, Gotoh T, Takiguchi M, Takeya M, Matsuzaki H, et al. Coinduction of nitric-oxide synthase and arginase I in cultured rat peritoneal macrophages and rat tissues in vivo by lipopolysaccharide. The Journal of Biological Chemistry. 1997; 272: 3689–3693. https://doi.org/10.1074/jbc.272.6.3689. |
| [44] |
Mori M, Gotoh T. Regulation of nitric oxide production by arginine metabolic enzymes. Biochemical and Biophysical Research Communications. 2000; 275: 715–719. https://doi.org/10.1006/bbrc.2000.3169. |
| [45] |
Devi VJ, Radhika A, Biju PG. Adenosine receptor activation promotes macrophage class switching from LPS-induced acute inflammatory M1 to anti-inflammatory M2 phenotype. Immunobiology. 2023; 228: 152362. https://doi.org/10.1016/j.imbio.2023.152362. |
| [46] |
Geller DA, Billiar TR. Molecular biology of nitric oxide synthases. Cancer Metastasis Reviews. 1998; 17: 7–23. https://doi.org/10.1023/a:1005940202801. |
| [47] |
Soskić SS, Dobutović BD, Sudar EM, Obradović MM, Nikolić DM, Djordjevic JD, et al. Regulation of Inducible Nitric Oxide Synthase (iNOS) and its Potential Role in Insulin Resistance, Diabetes and Heart Failure. The Open Cardiovascular Medicine Journal. 2011; 5: 153–163. https://doi.org/10.2174/1874192401105010153. |
| [48] |
Novak ML, Koh TJ. Macrophage phenotypes during tissue repair. Journal of Leukocyte Biology. 2013; 93: 875–881. https://doi.org/10.1189/jlb.1012512. |
| [49] |
Wang S, Wang J, Chen Z, Luo J, Guo W, Sun L, et al. Targeting M2-like tumor-associated macrophages is a potential therapeutic approach to overcome antitumor drug resistance. NPJ Precision Oncology. 2024; 8: 31. https://doi.org/10.1038/s41698-024-00522-z. |
| [50] |
Abdelaziz MH, Abdelwahab SF, Wan J, Cai W, Huixuan W, Jianjun C, et al. Alternatively activated macrophages; a double-edged sword in allergic asthma. Journal of Translational Medicine. 2020; 18: 58. https://doi.org/10.1186/s12967-020-02251-w. |
| [51] |
Rőszer T. Understanding the Mysterious M2 Macrophage through Activation Markers and Effector Mechanisms. Mediators of Inflammation. 2015; 2015: 816460. https://doi.org/10.1155/2015/816460. |
| [52] |
Du X, Ou X, Song T, Zhang W, Cong F, Zhang S, et al. Adenosine A2B receptor stimulates angiogenesis by inducing VEGF and eNOS in human microvascular endothelial cells. Experimental Biology and Medicine (Maywood, N.J.). 2015; 240: 1472–1479. https://doi.org/10.1177/1535370215584939. |
| [53] |
Jeon SH, Chae BC, Kim HA, Seo GY, Seo DW, Chun GT, et al. The PKA/CREB pathway is closely involved in VEGF expression in mouse macrophages. Molecules and Cells. 2007; 23: 23–29. |
| [54] |
Leibovich SJ, Chen JF, Pinhal-Enfield G, Belem PC, Elson G, Rosania A, et al. Synergistic up-regulation of vascular endothelial growth factor expression in murine macrophages by adenosine A(2A) receptor agonists and endotoxin. The American Journal of Pathology. 2002; 160: 2231–2244. https://doi.org/10.1016/S0002-9440(10)61170-4. |
| [55] |
Ahuja A, Kim E, Sung GH, Cho JY. STAT3 Differentially Regulates TLR4-Mediated Inflammatory Responses in Early or Late Phases. International Journal of Molecular Sciences. 2020; 21: 7675. https://doi.org/10.3390/ijms21207675. |
| [56] |
Waqas SFH, Ampem G, Röszer T. Analysis of IL-4/STAT6 Signaling in Macrophages. Methods in Molecular Biology (Clifton, N.J.). 2019; 1966: 211–224. https://doi.org/10.1007/978-1-4939-9195-2_17. |
| [57] |
Chen S, Saeed AFUH, Liu Q, Jiang Q, Xu H, Xiao GG, et al. Macrophages in immunoregulation and therapeutics. Signal Transduction and Targeted Therapy. 2023; 8: 207. https://doi.org/10.1038/s41392-023-01452-1. |
| [58] |
Pérez S, Rius-Pérez S. Macrophage Polarization and Reprogramming in Acute Inflammation: A Redox Perspective. Antioxidants (Basel, Switzerland). 2022; 11: 1394. https://doi.org/10.3390/antiox11071394. |
| [59] |
Liu Z, Kuang W, Zhou Q, Zhang Y. TGF-β1 secreted by M2 phenotype macrophages enhances the stemness and migration of glioma cells via the SMAD2/3 signalling pathway. International Journal of Molecular Medicine. 2018; 42: 3395–3403. https://doi.org/10.3892/ijmm.2018.3923. |
| [60] |
Munir MT, Kay MK, Kang MH, Rahman MM, Al-Harrasi A, Choudhury M, et al. Tumor-Associated Macrophages as Multifaceted Regulators of Breast Tumor Growth. International Journal of Molecular Sciences. 2021; 22: 6526. https://doi.org/10.3390/ijms22126526. |
| [61] |
Duluc D, Delneste Y, Tan F, Moles MP, Grimaud L, Lenoir J, et al. Tumor-associated leukemia inhibitory factor and IL-6 skew monocyte differentiation into tumor-associated macrophage-like cells. Blood. 2007; 110: 4319–4330. https://doi.org/10.1182/blood-2007-02-072587. |
| [62] |
Giurisato E, Xu Q, Lonardi S, Telfer B, Russo I, Pearson A, et al. Myeloid ERK5 deficiency suppresses tumor growth by blocking protumor macrophage polarization via STAT3 inhibition. Proceedings of the National Academy of Sciences of the United States of America. 2018; 115: E2801–E2810. https://doi.org/10.1073/pnas.1707929115. |
Natural Sciences and Engineering Research Council of Canada (NSERC) grants(RGPIN-2021-03093)
Ontario graduate scholarship
/
| 〈 |
|
〉 |